{"text": ["Novartis", "Announces", "Full", "Data", "From", "LIBERTY", "Study", "Of", "Aimovig"], "created_at": "2018-10-22 22:27:00"}
{"text": ["Novartis", "Announces", "Full", "Data", "From", "LIBERTY", "Study", "Of", "Aimovig"], "created_at": "2018-10-22 22:27:00"}
{"text": ["Novartis", "(NVS)", "Q3", "Earnings", "In", "Line,", "Revenues", "Beat", "Estimates"], "created_at": "2018-10-22 22:08:28"}
{"text": ["Novartis", "(NVS)", "Q3", "Earnings", "In", "Line,", "Revenues", "Beat", "Estimates"], "created_at": "2018-10-22 22:08:28"}
{"text": ["How", "Novartis\u2019s", "Innovative", "Medicines", "Business", "Performed", "in", "Q3"], "created_at": "2018-10-22 19:50:02"}
{"text": ["Novartis", "(NVS)", "Q3", "Earnings", "In", "Line,", "Revenues", "Beat", "Estimates"], "created_at": "2018-10-22 19:38:07"}
{"text": ["How", "Novartis\u2019s", "Business", "Segments", "Performed", "in", "the", "Third", "Quarter"], "created_at": "2018-10-22 18:20:02"}
{"text": ["Novartis", "Reports", "Third-Quarter", "Revenue", "Growth"], "created_at": "2018-10-22 16:49:53"}
{"text": ["BIIB,", "ALKS", "Q3", "Earnings", "Due", "on", "Oct", "23:", "What's", "in", "Store?"], "created_at": "2018-10-22 16:12:28"}
{"text": ["BIIB,", "ALKS", "Q3", "Earnings", "Due", "on", "Oct", "23:", "What's", "in", "Store?"], "created_at": "2018-10-22 16:12:28"}
{"text": ["BIIB,", "ALKS", "Q3", "Earnings", "Due", "on", "Oct", "23:", "What&apos;s", "in", "Store?"], "created_at": "2018-10-22 14:32:02"}
{"text": ["This", "tiny", "biotech", "spun", "a", "quick", "$2", "billion", "from", "$12", "million"], "created_at": "2018-10-22 12:08:00"}
{"text": ["Novartis", "Reveals", "New", "Data", "Analysis", "Of", "COMBI-AD", "Study", "Of", "Tafinlar", "With", "Mekinist"], "created_at": "2018-10-22 04:19:00"}
{"text": ["Novartis", "Reveals", "New", "Data", "Analysis", "Of", "COMBI-AD", "Study", "Of", "Tafinlar", "With", "Mekinist"], "created_at": "2018-10-22 04:19:00"}
